Galliprant Logo

Galliprant® (grapiprant tablets)

Help your patients enjoy the everyday moments that matter. Prescribe Galliprant to deliver targeted and effective pain relief from osteoarthritis pain and inflammation in dogs.

Why Choose Galliprant?

  • First-in-class non-COX inhibiting NSAID

  • Targeted Mode of Action

  • Use for All Stages of OA*

  • Safe to Use Daily

Galliprant Dosing and Administration

Weight (lbs) - 8-15
Weight (kg) - 3.6-6.8
20mg Tablet - 0.5 tablet
60mg Tablet - -
100mg Tablet - -
Weight (lbs) - 15.1-30
Weight (kg) - 6.8-13.6
20mg Tablet - 1 tablet
60mg Tablet - -
100mg Tablet - -
Weight (lbs) - 30.1-45
Weight (kg) - 13.7-20.4
20mg Tablet - -
60mg Tablet - 0.5 tablet
100mg Tablet - -
Weight (lbs) - 45.1-75
Weight (kg) - 20.5-34
20mg Tablet - -
60mg Tablet - 1 tablet
100mg Tablet - -
Weight (lbs) - 75.1-150
Weight (kg) - 34.1-68
20mg Tablet - -
60mg Tablet - -
100mg Tablet - 1 tablet
Dogs weighing less than 8 lbs (3.6 kg) cannot be accurately dosed. Only the 20 mg and 60 mg tablets of Galliprant are scored. Dosages should be calculated in half-tablet increments, except when using the 100 mg tablet because it is not scored and should not be broken in half. For dogs weighing more than 150 lbs (68 kg), use a combination of tablets and half tablets to achieve the appropriate dose.

How Galliprant Works

Mechanism of Action

  • Icon of EP4 receptor inside circle.

    First-in-class prostaglandin receptor antagonist (PRA); a non-COX inhibiting NSAID that specifically targets the EP4 receptor1

  • Icon of stomach with arrow pointing down.

    Mode of action targets canine OA pain and inflammation while reducing the impact on GI, kidney and liver homeostasis1,2†

Galliprant Resources

COAST Publication

How to Get Galliprant

Incorporate Galliprant into your canine OA protocol today.


Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.

Important Safety Information

Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long-term, appropriate monitoring is recommended. Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Click here for full prescribing information.